(±)-3-(4-Chlorophenyl)-2-aminopropanoic acid (Fenclonine, PCPA) is a selective, irreversible inhibitor of tryptophan hydroxylase, the rate-limiting enzyme in serotonin (5-hydroxytryptamine, 5-HT) biosynthesis; it depletes endogenous serotonin levels; it significantly attenuates monocrotaline (MCT)-induced pulmonary vascular remodeling and lung inflammation by inhibiting Tph-1 and modulating SERT and downstream serotonin signaling pathways; it suppresses the expression of Tph-1, SERT, MMP-2/-9, TIMP-1/-2, IL-1β, TNF-α, and ICAM-1.